DYN
Dyne Therapeutics Inc
NASDAQ: DYN · HEALTHCARE · BIOTECHNOLOGY
$17.41
-4.13% today
Updated 2026-04-29
Market cap
$2.88B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-3.47
Dividend yield
—
52W range
$8 – $25
Volume
2.2M
Dyne Therapeutics Inc (DYN) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.10B | $3.55B | $2.47B | $2.32B | $1.58B | $3.00M | $3.00M | $1.47B | $842.00M | $1.37B | $506.00M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | +14.4% | -30.5% | -5.9% | -31.8% | -99.8% | +0.0% | +48766.7% | -42.6% | +62.2% | -63.0% | -100.0% | — | — | — | — | — | — | — |
| Cost of revenue | $2.01B | $1.85B | $1.19B | $1.18B | $963.00M | $268.00M | $1.15B | $1.15B | $2.03B | $2.28B | $2.93B | $24000.00 | $271000.00 | $700000.00 | $1.09M | $3.35M | $2.46M | $2.24M | $2.05M |
| Gross profit | $1.09B | $1.70B | $1.27B | $1.14B | $622.00M | $-265.00M | $-1.14B | $321.00M | $-1.19B | $-915.00M | $-2.43B | $-24000.00 | $-271000.00 | $-700000.00 | $-1.09M | $-3.35M | $-2.46M | $-2.24M | $-2.05M |
| Gross margin | 35.1% | 47.8% | 51.6% | 49.2% | 39.2% | -8833.3% | -38066.7% | 21.9% | -140.9% | -67.0% | -479.4% | — | — | — | — | — | — | — | — |
| R&D | — | — | — | — | — | — | — | — | — | — | — | $4.28M | $11.04M | $45.20M | $121.31M | $142.76M | $210.76M | $281.41M | $398.33M |
| SG&A | $203.00M | $157.00M | $159.00M | $163.00M | $135.00M | $22.00M | $97.00M | $97.00M | $128.00M | $161.00M | $189.00M | $517000.00 | $2.79M | $13.45M | $28.72M | $28.20M | $31.40M | $62.48M | $69.85M |
| Operating income | $605.00M | $709.00M | $-834.00M | $-11.00M | $-236.00M | $714.00M | $-318.00M | $-318.00M | $64.00M | $-640.00M | $-412.00M | $-4.79M | $-13.83M | $-58.65M | $-150.03M | $-170.96M | $-242.16M | $-343.89M | $-468.18M |
| Operating margin | 19.5% | 20.0% | -33.8% | -0.5% | -14.9% | 23800.0% | -10600.0% | -21.7% | 7.6% | -46.9% | -81.4% | — | — | — | — | — | — | — | — |
| EBITDA | $830.00M | $902.00M | $-173.00M | $734.00M | $-1.57B | $113.00M | $150.00M | $292.00M | $736.00M | $106.00M | $949.00M | $-4.79M | $-14.59M | $-57.95M | $-148.94M | $-169.28M | $-233.48M | $-315.18M | $-437.97M |
| EBITDA margin | 26.7% | 25.4% | -7.0% | 31.6% | -99.3% | 3766.7% | 5000.0% | 19.9% | 87.4% | 7.8% | 187.5% | — | — | — | — | — | — | — | — |
| EBIT | $497.00M | $526.00M | $-532.00M | $326.00M | $-1.92B | $87.00M | $-317.00M | $0.00 | $122.00M | $-660.00M | $82.00M | $-4.81M | $-14.86M | $-58.65M | $-150.03M | $-170.96M | $-235.94M | $-317.42M | $-440.02M |
| Interest expense | $384.00M | $427.00M | $415.00M | $363.00M | $357.00M | $0.00 | $97.00M | $67.00M | $546.00M | $625.00M | $616.00M | $5000.00 | $290000.00 | $396000.00 | $742000.00 | $2.92M | $0.00 | $0.00 | $6.19M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $264.00M | $174.00M | $-1.26B | $-234.00M | $-1.65B | $87.00M | $-356.00M | $-67.00M | $50.00M | $-1.24B | $76.00M | $-4.81M | $-13.54M | $-58.74M | $-149.29M | $-165.24M | $-235.94M | $-317.42M | $-446.21M |
| Net income growth (YoY) | — | -34.1% | -825.3% | +81.5% | -603.0% | +105.3% | -509.2% | +81.2% | +174.6% | -2580.0% | +106.1% | -106.3% | -181.4% | -333.9% | -154.2% | -10.7% | -42.8% | -34.5% | -40.6% |
| Profit margin | 8.5% | 4.9% | -51.1% | -10.1% | -103.8% | 2900.0% | -11866.7% | -4.6% | 5.9% | -90.8% | 15.0% | — | — | — | — | — | — | — | — |